Table 3.
Univariate analysis and multivariate analysis of the correlation of GPX8 expression with OS among gastric cancer patients.
| Parameter | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P | HR | 95% CI | P | |
| Age (continuous) | 1.03 | 1.01–1.05 | 0.006 | |||
| Gender (Male vs. Female) | 1.48 | 0.98–2.25 | 0.062 | |||
| Grade (G1 vs. G2/G3) | 1.37 | 0.95–1.98 | 0.095 | 1.27 | 0.87–1.86 | 0.211 |
| Stage (Stage I vs. Stage II/Stage III/Stage IV) | 1.54 | 1.22–1.93 | 0.000 | 1.38 | 0.89–2.14 | 0.148 |
| T (T1 vs. T2/T3/T4) | 1.30 | 1.02–1.65 | 0.032 | 0.99 | 0.72–1.36 | 0.938 |
| M (M0 vs. M1) | 2.05 | 1.10–3.83 | 0.025 | 1.45 | 0.65–3.25 | 0.365 |
| N (N0 vs. N1/N2/N3) | 1.27 | 1.07–1.50 | 0.006 | 1.06 | 0.83–1.36 | 0.621 |
| GPX8 (low vs. high) | 1.05 | 1.01–1.08 | 0.018 | 1.04 | 1.00–1.08 | 0.041 |